Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya30005Editorial articleПередовая статьяFrom a patient to discovery: a conventional approach to detection of unkown diseases and components of the biological systemsОт больного - к открытию: традиционный путь распознавания ранее неизвестных болезней и компонентов биологических системBarkaganZ SБаркаганЗ С

Барнаул; Алтайский филиал ГНЦ РАМН; ЦНИЛ Алтайского медицинского университета

Алтайский филиал ГНЦ РАМНЦНИЛ Алтайского медицинского университета15072004797NO7 (2004)ТОМ 79, №7 (2004)929409042020Copyright ©; 2004, Consilium MedicumCopyright ©; 2004, ООО "Консилиум Медикум"2004Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/30005

coagulation factorshemophiliacoagulationbleedingthrombosesфакторы свертываниягемофилиясвертываемость кровикровоточивостьтромбозыSchmidt A. Die Lehre von den fermentativen Gerinnungserscheinungen in den eiweissartigen thierschen Korperfliissigkeiten. Dorpat: С Mattiesen; 1877.Morewitz P. Beitrage zur Kenntniss der Blutgerinnung 1 und 2 Mitteilunges. Dtsch. Arch. Klin. Med. 1903; 79: 1-28.Patek A. Y., Taylor F. H. L. Haemophilia, II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. J. Clin. Invest. 1937; 16 (1): 113-124.Pavlovsky A. Contribution to the pathogenesis of hemophilia. Blood 1947; 2: 185-191.Biggs R., Douglas A. S., Macfarlave R. G. et al. Christmas disease: a condition previously mistaken for haemophilia. Br. Med. J. 1952; 2: 1378-1382.Aggeler P. M., White S. G., Glendening M. B. et al. Plasma thromboplastin component (PTC) deficiency: a new disease resembling hemophilia. Proc. Soc. Exp. Biol.(N. Y.) 1952; 79: 692-694.Owren P. A. The coagulation of blood: investigation of a new clotting factor. Acta Med. Scand. 1947; suppl. 194: 1-327.Owren P. A. The fifth coagulation factor (factor V). Preparation and properties. Biochem. J. 1948; 43: 136-139.Dachlback В., Carlsson M. Familial thrombophilia due to a previously unrecognized mechanism characterized by resistance to activatged protein С Thromb. Haemost. 1993; 69 (suppl.): abstr. 988.Dachlback B. The discovery of activatged protein С resistance. J. Thromb. Haemost. 2003; 1 (1): 3-9.Bertina R. M., Koeleman B. P., Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein С Nature 1994; 369: 64-67.Svensson P. J., Dachlback B. Resistance to activated protein С as a basis for venous thrombosis. N. Engl. J. Med. 1994; 330: 517-522.Barkagan Z. S., Tsyvkina L. P., Mamaev A. N., Tseimakh I. A. Prevalence of APC-resistance among the patients with early thrombosis in the Siberian region of Russia. Thromb. Haemost. 1997; suppl.: 223, abstr. PS-206.Norstrom E., Thorelti E., Dachlback B. Functional characterization of recombinant FV Cambridge and FV Hong Kong. Blood 2002; 100: 524-530.Graham J. В., Barrow E. M., Hougie С Stuart clotting defect II. Genetic aspects of a "new" hemorhagic state. J. Clin. Invest. 1957; 36: 497-503.Tefler T. P., Denson K. W., Wright D. R. A "new" coagulation defect. Br. J. Haematol. 1956; 2: 308-316.Ratnoff O. D., Colopy J. E. A familial trait associated with deficiency of a clot-promoting fraction of plasma. J. Clin. Invest. 1955; 34 (4): 602-613.Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb. Diathes. Haemorrh. 1965; 13: 516-530.Баркаган 3. С., Бшиевский К. М., Суховеева Е. Я. Первичная тромбофилия, обусловленная дефицитом антитромбина III. Тер. арх. 1978; 8: 101-106.